MT
MetaVia Inc.
MTVA · NASDAQ
$1.67 -0.60% (-$0.01)
1M +13.07%
Market Cap $3.81M
P/E Ratio -
Div. Yield -
ROE 209.67%
Bulios Fair Price
$2.29
37.1% upside
Trenutna cena
$1.67
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MTVA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.56x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 37.41%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 213.33%
ROE 209.67%
ROA 108.85%
Debt
100 /100
Low Debt/Equity 0.03x
Current ratio 2.06x
Int. coverage N/A
Stability
37 /100
Moderate Beta 0.94x
EPS volatility 76.78%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MTVA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hyung Heon Kim
Employees
8
Headquarters
Cambridge
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report